Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C.

A Padkin; K Rowan; N Black ORCID logo; (2001) Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C. BMJ (Clinical research ed), 323 (7318). pp. 923-926. ISSN 0959-8138 DOI: 10.1136/bmj.323.7318.923
Copy
Item Type Article
Keywords Care, Anticoagulants, therapeutic use, Clinical Protocols, Databases, Factual, Evidence-Based Medicine, methods, Human, Intensive Care, methods, Policy Making, Protein C, therapeutic use, Randomized Controlled Trials, Recombinant Proteins, therapeutic use, Sepsis, drug therapy, Support, Non-U.S. Gov't
ISI 171798200028

Explore Further

picture_as_pdf
923.full.pdf
subject
Published Version
Available under Creative Commons: NC 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads